HLA-DR17 and Mooren's Ulcer in South India
- Joseph R. Zelefsky MD (jzelefsk{at}yahoo.com),
- Craig J. Taylor, PhD (craig.taylor{at}addenbrookes.nhs.uk),
- Muthaiah Srinivasan MD (m.srinivasan{at}aravind.org),
- Sarah Galasinski, BSc,
- Reyna S. Goodman, BSc,
- Timothy Key, MSc,
- Peter G. Watson MD,
- Emmett T. Cunningham, Jr. (emmett_cunningham{at}yahoo.com)
- New York University, United States
- Cambridge University Hospitals NHS Foundation Trust, United Kingdom
- Aravind, India
- Cambridge University Hospitals NHS Foundation Trust, United Kingdom
- Cambridge University Hospitals NHS Foundation Trust, United Kingdom
- Cambridge University Hospitals NHS Foundation Trust, United Kingdom
- Cambridge University Hospitals NHS Foundation Trust, United Kingdom
- Francis I. Proctor Foundation, UCSF School of Medicine, United States
- Published Online First 22 January 2008
Abstract
Objective: To investigate the association between Mooren's ulcer and human leukocyte antigen (HLA) type DR17(3) in patients from the Tamil Nadu State of South India .
Methods: Blood samples from 38 patients with Mooren's ulcer and 45 age- and sex-matched controls were obtained prospectively. HLA-DR and -DQ typing was performed by polymerase chain reaction (PCR) using sequence specific primers.
Results: Fifteen (39.5%) of the Mooren's ulcer patients tested positive for HLA-DR17(3), as compared to seven (15.6%) of the controls (p=0.01). Seventeen (44.7%) of the Mooren’s ulcer patients also tested positive for the closely linked HLA-DQ2, as compared to eleven (24.4%) of controls (p=0.05). When adjusted for multiplicity, the correlation between HLA-DR17(3) and Mooren's ulcer remained statistically significant (p=0.03).
Conclusions: These data demonstrate an association between HLA-DR17(3) and Mooren's ulcer in South Indian patients, supporting autoimmune theories in the pathogenesis of the disorder.







